-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Considerable progress has been made in uncovering the complex molecular mechanisms of amyotrophic lateral sclerosis (ALS)
Registered ALS patients were analyzed
A population-based cohort of 1043 patients diagnosed with amyotrophic lateral sclerosis was analyzed and included in PARALS
Distribution of mutated genes in the cohort
A medium-length ATXN2 CAG expansion (30-33 repeats) was the only high-risk genetic factor (defined as OR ≥ 2.
In the population-based ALS cohort, a higher proportion of patients with pathogenic variants were detected (26.
Population-based assessments reveal the complex genetics of ALS and provide a valuable benchmark for the current state of the field